PHILADELPHIA, Aug. 26 /PRNewswire-FirstCall/ -- ERT (Nasdaq: ERES), announced the appointment of a new Associate Director of Business Development - Japan, Miki Stevens. In this new role, Ms. Stevens will work with ERT's Japanese partner, Site Support Institute (SSI), to facilitate sales activities and to provide enhanced in-country support of Japanese sponsors and clinical trial sites. By nurturing existing strategic partnerships, Ms. Stevens will focus on increasing ERT's Japan-based and other Far Eastern sales, supporting the demands of customers worldwide.
Ms. Stevens joins ERT from PAREXEL International Inc. (Tokyo) where she worked as an Account Manager in Business Development, managing relations with biopharmaceutical and medical device clients and successfully launched the marketing department.
"ERT has established relationships with alliance partners worldwide that offer its clients seamless integration points across their clinical trial needs," commented Robert Brown, SVP, Strategic Marketing, Planning and Partnerships at ERT. "We are delighted to welcome Miki to the ERT team. This new appointment continues our investment in the Japanese and wider Pacific Rim markets helping us to expand our direct sales reach and service the needs of our clients in the best possible way."
For further press information, please contact Fiona Robinson, The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA, United Kingdom. Phone +44 1477 539539, fax +44 1477 539540, email email@example.com.
Based in Philadelphia, PA, ERT (eResearchTechnology, Inc.) (www.ert.com) is a leading provider of centralized ECG, ePRO, and other services to the biopharmaceutical, medical device, and related industries. ERT products and services include ERT Cardiac Safety Solutions, ERT ePRO Solutions, and ERT Clinical Research Consulting Group -- enabled by the Company's innovative technology platform -- EXPERT(R). EXPERT is a robust, secure, and validated clinical research workflow-processing system that powers centralized electronic data collection, data management, and information exchange.
Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties, which could cause actual results to differ materially from those expressed or implied from such statements. These risks and uncertainties include, without limitation, the Company's ability to obtain new contracts, variability in size, scope and duration of projects, integration of acquisitions, competitive factors, technological development, market demand, and other factors described in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.
Copyright©2009 PR Newswire.
All rights reserved